The Nutraceutical / Dietary Supplements CGMPs per 21 CFR 111

Posted By : User Ref No: WURUR64360 0
  • Image
  • TypeWebinar
  • Image
  • Location Palo Alto, California, United States
  • Price
  • Date 27-10-2020
Webinar Title
The Nutraceutical / Dietary Supplements CGMPs per 21 CFR 111
Event Type
Webinar
Webinar Date
27-10-2020
Last Date for Applying
27-10-2020
Location
Palo Alto, California, United States
Organization Name / Organize By
Complianceonline
Organizing/Related Departments
Complianceonline
Organization Type
Organization/Company
WebinarCategory
Both (Technical & Non Technical)
WebinarLevel
All (State/Province/Region, National & International)
Related Industries
Location
Palo Alto, California, United States

This webinar will evaluate the chief areas of the Dietary Supplements FDA CGMP compliance requirements as required by in 21 CFR 111, the US Law – this and related regulations mandate a ‘total quality system’ -- from customer requirements thru development, production, to customer use/feedback. Labeling requirements will also be discussed, including those uniquely geared to nutraceuticals. The steps resulting in the present FDA regulatory requirements will be reviewed. This webinar can also be a significant part of meeting a company’s annual CGMP training requirement (if properly supplemented and documented) for a neutraceutical company.

Why Should You Attend:

The US FDA issued a final rule (law) regarding current good manufacturing practice (CGMP) for dietary supplements in August 2007, 21 CFR 111, Dietary Supplements CGMPs. It established the minimum CGMPs necessary for activities related to manufacturing, packaging, labeling, or holding dietary supplements to ensure the quality of the dietary supplement. It is one of many actions related to dietary supplements that the FDA has taken to promote and protect the public health, when voluntary / trade association inspections failed to do so. Even with this recent law, some companies have continued to add undeclared / illegal ingredients to some dietary supplements, especially in weight loss and sexual enhancement products. What is required to be in compliance, in raw materials, in production, testing, and documentation?

Areas Covered in the Webinar:

  • Basic U.S. FDA's expectations
  • US government legal history on dietary supplements
  • The dietary supplements CGMPs, 21 CFR 111
  • Current FDA Expectations / Requirements
  • Implementation expectations / requirements
  • Key dietary supplement CGMP concerns
  • Current serious industry issues

Who Will Benefit:

  • Senior and middle management
  • QA / QC
  • RA
  • R&D
  • Formulation
  • Engineering
  • Staff and Line personnel
  • Sales and Marketing
  • Operations / Production

From Dietary Supplements / Nutraceuticals industries

Registration Fees
Not Mention
Registration Ways
Email
Phone
Website
Address/Venue
  2479 E. Bayshore Road, Suite 260  Pin/Zip Code : 94303
Landmark
California
Official Email ID
Contact
Ashutos Swain

2479 E. Bayshore Road, Suite 260

[email protected]

   8887172436    Fax No: 94303
Ashutos Swain